Search details
1.
Invasion of the germinal centers.
Cell
; 186(1): 12-14, 2023 01 05.
Article
in English
| MEDLINE | ID: mdl-36608649
2.
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Cell
; 185(3): 457-466.e4, 2022 02 03.
Article
in English
| MEDLINE | ID: mdl-34995482
3.
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Nat Immunol
; 25(3): 537-551, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38337035
4.
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Cell
; 184(9): 2372-2383.e9, 2021 04 29.
Article
in English
| MEDLINE | ID: mdl-33743213
5.
COVID-19-neutralizing antibodies predict disease severity and survival.
Cell
; 184(2): 476-488.e11, 2021 01 21.
Article
in English
| MEDLINE | ID: mdl-33412089
6.
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.
Cell
; 184(19): 4969-4980.e15, 2021 09 16.
Article
in English
| MEDLINE | ID: mdl-34332650
7.
InĀ vitro and inĀ vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
Cell
; 184(16): 4203-4219.e32, 2021 08 05.
Article
in English
| MEDLINE | ID: mdl-34242577
8.
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
Cell
; 183(6): 1508-1519.e12, 2020 12 10.
Article
in English
| MEDLINE | ID: mdl-33207184
9.
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
Cell
; 183(6): 1496-1507.e16, 2020 12 10.
Article
in English
| MEDLINE | ID: mdl-33171099
10.
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
Cell
; 183(4): 1043-1057.e15, 2020 11 12.
Article
in English
| MEDLINE | ID: mdl-32970989
11.
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
Cell
; 183(1): 143-157.e13, 2020 10 01.
Article
in English
| MEDLINE | ID: mdl-32877699
12.
Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism.
Cell
; 177(5): 1124-1135.e16, 2019 05 16.
Article
in English
| MEDLINE | ID: mdl-31100267
13.
Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses.
Immunity
; 57(5): 1141-1159.e11, 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38670113
14.
Author Correction: Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Nat Immunol
; 25(3): 578, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38360936
15.
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses.
Immunity
; 55(10): 1856-1871.e6, 2022 10 11.
Article
in English
| MEDLINE | ID: mdl-35987201
16.
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Cell
; 184(9): 2523, 2021 Apr 29.
Article
in English
| MEDLINE | ID: mdl-33930298
17.
Viral receptor-binding site antibodies with diverse germline origins.
Cell
; 161(5): 1026-1034, 2015 May 21.
Article
in English
| MEDLINE | ID: mdl-25959776
18.
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival.
Immunity
; 53(3): 524-532.e4, 2020 09 15.
Article
in English
| MEDLINE | ID: mdl-32783920
19.
Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires.
Immunity
; 48(1): 174-184.e9, 2018 01 16.
Article
in English
| MEDLINE | ID: mdl-29343437
20.
Complex Antigens Drive Permissive Clonal Selection in Germinal Centers.
Immunity
; 44(3): 542-552, 2016 Mar 15.
Article
in English
| MEDLINE | ID: mdl-26948373